- Remove All
- Your shopping cart is currently empty
- A unique collection of 343 protease and proteasome inhibitors for research in chemical genomics, and drug screening;
- Targets include proteasome, DPP-4, Serine protease, cysteine protease, MMP, Aspartic proteinases, etc;
- Bioactivity and safety confirmed by pre-clinical research and clinical trials, and some of them are approved by FDA;
- Detailed compound information with structure, target, activity, IC50 value, and biological activity description;
- Structurally diverse, medicinally active, and cell permeable;
- NMR and HPLC validated to ensure high purity and quality;